ECE2023 Oral Communications Oral Communications 7: Pituitary and Neuroendocrinology 2 (6 abstracts)
The mesenchymal stem cells induce immunosuppressive microenvironment in pituitary tumors
Daniel Marrero-Rodríguez 1 , Keiko Taniguchi 2 , Victor A Cortes-Morales 3 , Alejandra Valenzuela-Perez 2 , Sandra Vela-Patiño 2 , Amayrani Cano-Zaragoza 2 , Florencia Martinez 2 , Jacobo Kerbel 2 , Sergio Andonegui-Elguera 2 , Erick Gomez-Apo 4 , Laura Chavez-Macias 4 , Juan Jose Montesinos 3 & Moises Mercado 2
1Hospital de Especialidades CMN Siglo XXI IMSS, UIMEE, Ciudad de México, Mexico; 2Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Unidad de Investigación Medica en Enfermedades Endocrinas, Mexico; 3Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Unidad de Investigación Medica en Enfermedades Oncologicas, Mexico; 4Hospital General de México Dr. Eduardo Liceaga, Área de Neuropatología, Servicio de Anatomía Patológica, Mexico
The tumor microenvironment (TME) includes diverse cellular components such as mesenchymal stem cells (MSC) and immune cells. MSC are a subset of heterogeneous cell populations characterized by the expression of CD105, CD73, and CD90 that can differentiate into chondrocytes, osteoblasts, and adipocytes in vitro. They are known to have immunomodulatory capabilities. Our aim was to isolate and characterize the immunomodulatory capabilities of MSC from pituitary tumors (PT) and non-tumoral gland as well as to describe the immune TME. We isolated and cultivated MSC from LH/FSH-PT and ACTH-PT, as well as non-tumoral pituitary glands. The MSC obtained from PT and non-tumoral gland were co-cultured in the presence of monocytes from healthy donors and their ability to transform into M0, M1 or M2 macrophages was assessed by flow cytometry. The results showed that pituitary tumors derived MSC induce an immunosuppressive M2 macrophage state, by increasing the expression of CD14 and CD206 markers, and decreasing HLA-DR. Upon co-culturing them with naïve T cells, PT MSC were capable inducing a Treg phenotype. To identify PT TME, we performed tumor whole transcriptome characterization and cellular deconvolution using CIBERSORT. Our analysis was indicative of a strong presence of M2 macrophages, TCD4+ and TCD8+ cells, which was confirmed by immunofluorescence, suggesting an immunosuppressive TME. Thus, the MSC immunosuppressive induction correlates directly with immune TME. ACTH-PT derived MSC showed a stronger anti-inflammatory activity than LH/FSH-PT. We also characterized the transcriptomic differences between non-tumoral and PT derived MSC by means of RNAseq. We found differences between the non-tumoral MSC and pituitary tumor derived MSC, but mainly between ACTH- and LH/FSH-PT derived MSC. In conclusion our data suggest that the presence of MSC influence an immunosuppressive tumor microenvironment alongside with tumor cells.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more